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An epidemic of infections by rapidly growing mycobacteria related to surgical procedures between 2004 and
2008 in Brazil was caused by a unique strain showing the Mycobacterium abscessus type 2 pattern when it was
analyzed by the molecular method of PCR-restriction enzyme analysis of the hsp65 gene (PRA-hsp65). In order
to investigate the diversity ofM. abscessus type 2 clinical isolates and to assess whether this epidemic strain was
present in specimens from nonsurgical patients, we studied 52 isolates from 38 patients showing this charac-
teristic PRA-hsp65 pattern obtained between 2005 and 2009. All isolates were identified by sequencing of region
V of the rpoB gene and typed by pulsed-field gel electrophoresis (PFGE) using two restriction enzymes, DraI
and AseI. Seven isolates obtained from sputum, bronchoalveolar lavage fluid, and urine in three different
Brazilian states showed rpoB sequences 100% similar to the rpoB sequence of epidemic strain INCQS 594 and
PFGE patterns highly related to the patterns of isolates, evidencing the presence of the epidemic strain in
isolates from patients not associated with the surgical epidemic. The remaining isolates showed diverse rpoB
sequences, with the highest similarities being to the corresponding sequences ofM. massilienseT CIP 108297 (21
isolates), M. bolletiiT CIP 108541 (19 isolates), or M. abscessusT ATCC 19977 (5 isolates). Two additional
clusters could be detected by PFGE. PFGE showed 100% typeability and reproducibility and discriminatory
powers, calculated by Simpson’s index of diversity, of 0.978 (DraI) and 0.986 (AseI), confirming its suitability
for the discrimination of M. abscessus type 2 isolates.
Outbreaks of infections caused by rapidly growing mycobac-
teria (RGM) related to surgical and cosmetic procedures have
concerned Brazilian health care authorities since 2003 (5, 12,
19, 22–24, 28). More than 2,000 notifications received between
2004 and 2008 by the Brazilian National Health Surveillance
Agency (ANVISA) reported cases of RGM surgical-site infec-
tions after laparoscopic, arthroscopic, or plastic surgeries (4,
19). Most isolates recovered from surgical patients studied so
far showed three common features: an uncommon pattern
when they were submitted to PCR-restriction enzyme analysis
of the hsp65 gene (PRA-hsp65), called Mycobacterium absces-
sus type 2 by Devallois et al. (10) and others (19); two char-
acteristic substitutions [C(2683)T and T(2874)C] in the se-
quence of region V of the rpoB gene (2, 19, 28); and two highly
similar patterns with one band difference when they were typed
by pulsed-field gel electrophoresis (PFGE) using DraI and
AseI restriction enzymes (5, 12, 19, 28). The Brazilian National
Institute for Health Quality Control (INCQS) deposited one of
these isolates under number INCQS 594.
This PRA-hsp65 pattern was ascribed to two recently de-
scribed members of the Mycobacterium chelonae-M. abscessus
group: Mycobacterium massiliense and Mycobacterium bolletii
(1, 3). Extensive phenotypic and genotypic analysis of members
of the M. chelonae-M. abscessus group has recently demon-
strated that M. massiliense and M. bolletii cannot be separated
from M. abscessus, supporting the proposition that the three
taxa represent a single species, namely, M. abscessus. Two
subspecies, “M. abscessus subsp. abscessus” (which includes
former M. abscessus isolates) and “M. abscessus subsp. massil-
iense” (which includes isolates identified as M. massiliense and
M. bolletii) (18), were also proposed. Eventually, the name M.
abscessus subsp. massiliense was corrected to M. abscessus
subsp. bolletii, in accordance with the rules of the International
Code of Nomenclature of Bacteria (1990 revision) (11, 16, 17a).
According to this new arrangement, the strain associated with
most surgical outbreak cases in different states in Brazil, iden-
tified here as the epidemic strain, is ascribed to M. abscessus
subsp. bolletii.
Few publications have described clinical isolates in Brazil
showing the M. abscessus type 2 PRA-hsp65 pattern, and the
real incidence of these infections is not known (27). In two
separate studies, Da Silva Rocha et al. (8, 9) analyzed 43 and
356 clinical isolates using PRA-hsp65 and found 1 and 8 iso-
lates showing the M. abscessus type 2 pattern, respectively.
Suffys et al. (25) detected this PRA-hsp65 pattern in 8 of 110
clinical isolates. Chimara et al. (6) analyzed 439 nontubercu-
lous mycobacterial (NTM) isolates received in a reference
laboratory between 2000 and 2001 and found only two isolates
with the M. abscessus type 2 pattern. None of these isolates was
analyzed by rpoB sequencing or PFGE.
The aim of this study was to investigate the diversity of
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clinical isolates showing the M. abscessus type 2 pattern and to
estimate the presence of the epidemic strain among clinical
isolates not recognized to be epidemiologically related to out-
breaks. This information can add to the current knowledge
about the possible source(s) of these surgical infections in
Brazil. In addition, we evaluated the efficiency of PFGE for the
discrimination of M. abscessus type 2 isolates.
MATERIALS AND METHODS
Mycobacterial isolates. The study included clinical mycobacterial isolates re-
ceived for identification between 2005 and 2009 at the Universidade Federal do
Rio de Janeiro, Rio de Janeiro, Rio de Janeiro State (RJ), Brazil, and at the
Instituto Adolfo Lutz, Sao Paulo, Sa˜o Paulo State (SP), Brazil (Table 1). The
inclusion criteria for this study were that isolates showed the M. abscessus type 2
PRA-hsp65 pattern and were not received in the laboratories as isolates from
surgical-site infections. Isolates with other PRA-hsp65 patterns were excluded
from this study. Clinical and epidemiological data for the patients were obtained
from laboratory records or from notifications received by local surveillance
services as part of routine monitoring and were analyzed anonymously.
M. abscessusT ATCC 19977, M. chelonaeT ATCC 35752, M. immunogenumT
ATCC 700505, M. massilienseT CCUG 48898, M. bolletiiT CCUG 50184, two
outbreak isolates (INCQS 594 and B52) obtained from surgical patients, and one
unrelated isolate from a postinjection abscess (B67) previously analyzed by our
group during the outbreak of surgical-site infections in Bele´m, Para´ (PA), Brazil,
were included for comparison (28).
Isolates were cultivated in Middlebrook 7H9 liquid medium (Becton Dickin-
son and Company, Sparks, MD) or Middlebrook 7H10 agar (Becton Dickinson
and Company) plates supplemented with oleic acid, albumin, dextrose, and
catalase (OADC; Becton, Dickinson and Company) at 37°C. Frozen stocks were
stored in 7H9 liquid medium-OADC and 15% glycerol at 80°C.
Species identification. Species identification was confirmed by sequencing of
region V of the rpoB gene, as described by Ade´kambi et al. (2). Other conserved
regions in the mycobacterium genome, such as the hsp65, gyrA, and gyrB genes
and the 16S-23S internal transcribed sequence (ITS), were sequenced to confirm
the identification of isolates showing discordant results by PRA-hsp65 and rpoB
sequencing.
Sequence similarity analysis. Sequences were analyzed for their similarity with
sequences in the GenBank database using the Basic Local Alignment Tool
(BLAST; http://www.ncbi.nlm.nih.gov/BLAST).
The alignment of the rpoB gene sequences was performed using ClustalX
(version 2.0) software (17). Phylogenetic trees were constructed using M. tuber-
culosis strain H37Rv (ATCC 27294) as an outgroup. The evolutionary history
was generated using the neighbor-joining method. The evolutionary distances
were computed using the Kimura two-parameter model and bootstrap analysis
with 1,000 replications. Phylogenetic analysis was performed using MEGA4
software (26).
PFGE. Isolates were typed by PFGE, as described by Leao et al. (19). Briefly,
single colonies were grown at 37°C in Mueller-Hinton broth supplemented with
0.1% Tween 80 until an optical density of 0.64 at 650 nm was reached. Plugs of
bacterial cells were prepared in 1% low-melt preparative-grade agarose (Bio-
Rad Laboratories Inc., Hercules, CA). DNA was isolated from the plug molds
and digested with 30 U DraI (Promega, Madison, WI) or AseI (Fermentas,
Vilnius, Lithuania) at 37°C overnight. Plugs were loaded into 1% pulsed-field-
certified agarose (Bio-Rad) in 0.5% TBE buffer (45 mM Tris-HCl, 45 mM boric
acid, 1 mM EDTA), and electrophoresis was carried out in a CHEF-DR III
system (Bio-Rad) at 14°C for 21 h at 6 V/cm with a switch time of 1.6 to 21.3 s.
Bacteriophage lambda ladder PFG Marker (New England Biolabs, Ipswich, MA)
was used as a molecular size standard. PFGE gel images were analyzed with the
BioNumerics (version 5.1) program (Applied Maths, Sint-Martens-Latem, Bel-
gium). The band-based Dice unweighted-pair group method using average link-
ages was used to prepare dendrograms of PFGE profiles, based on 2% optimi-
zation and position tolerance.
The efficiency of the PFGE typing method for M. abscessus type 2 isolates was
estimated by the quantification of typeability, reproducibility, and discriminatory
power, evaluated by calculating the numerical index of discrimination (D), based
on Simpson’s index of diversity, as previously described (14).
Nucleotide sequence accession numbers. The rpoB, hsp65, gyrA, gyrB, and
16S-23S ITS sequences of the isolates included in this study were deposited in the
GenBank database under accession numbers FJ859893, FJ859894, and
HQ404261 to HQ404300.
RESULTS
Patients’ data. Among the 38 patients included in this study,
32 (84.2%) had isolates obtained from sputum (Table 1).
Twenty-one of these 32 patients had suggestive clinical and/or
radiological findings and more than two sputum isolates, meet-
ing the diagnostic criteria for NTM lung disease according to
the official ATS/IDSA statement (13). Not all isolates from
these patients were included in this study, because some were
retrieved outside the study period and others were processed
in local laboratories. Eleven patients had only one sputum
sample, but three were previously treated for pulmonary tu-
berculosis and were again under investigation for lung disease,
TABLE 1. Rapidly growing mycobacterial clinical isolates
presenting the M. abscessus type 2 pattern included
in this study
Patient Isolatea
No. of
isolates
per patientb
Yr of isolation Stated
1 IAL 001 1 2005 CE
2 IAL 002 1 2005 CE
3 IAL 003 1 2005 CE
4 IAL 004 1 2006 CE
5 IAL 005 1 2006 CE
6 IAL 006 1 2006 CE
7 IAL 007 1 2008 DF
8 IAL 008 1 2007 MS
9 IAL 009 1 2006 MS
10 IAL 010 1 2007 MT
11 IAL 011 1 2007 PI
12 IAL 012 1 2005 SP
13 IAL 013 1 2005 SP
14 IAL 014 1 2006 SP
15 IAL 015 1 2006 SP
16 IAL 016 1 2007 SP
17 IAL 017 1 2007 SP
18 IAL 018 1 2007 SP
19 IAL 019 1 2007 SP
20 IAL 020c 1 2006 SP
21 IAL 021 3 2006 SP
22 IAL 024 4 2005, 2006, 2007 SP
23 IAL 028 1 2008 SP
24 IAL 029 5 2005, 2006, 2007 SP
25 CRM 375 3 2008 RJ
26 CRM 409 2 2008 RJ
27 CRM 473 2 2009 RJ
28 CRM 512 2 2009 RJ
29 CRM 573 1 2009 RJ
30 CRM 642 1 2009 RJ
31 CRM 270c 1 2007 RJ
32 CRM 273c 1 2007 RJ
33 CRM 622c 1 2009 RJ
34 CRM 552c 1 2009 RJ
35 IAL 034c 1 2006 SP
36 IAL 035 1 2007 SP
37 IAL 036c 1 2006 CE
38 IAL 037 1 2006 SP
a Sources: IAL 001 to CRM 273, sputum; CRM 622 to IAL 034, bronchoal-
veolar lavage fluid; IAL 035, blood; IAL 036, urine; IAL 037, parotid nodule.
b Data for only one isolate per patient are shown.
c Isolates showing rpoB sequences 100% similar to the sequence of the epi-
demic strain and PFGE patterns highly similar to those of isolates of the epi-
demic strain.
d Abbreviations for Brazilian states: CE, Ceara´; DF, Distrito Federal; MS,
Mato Grosso do Sul; MT, Mato Grosso; PI, Piauı´; RJ, Rio de Janeiro; SP, Sa˜o
Paulo.
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suggesting probable disease. Among the 32 patients with spu-
tum isolates, previous tuberculosis treatment was documented
in 12 and cystic fibrosis was documented in 3. The mean age of
these patients was 51  22.5 years, and the median age was 52
years. Eighteen patients were male and 14 were female. For
the remaining six patients, local surveillance services were not
notified. Three isolates were obtained with the use of bron-
choscopes. Two isolates were obtained from sterile sites (blood
and a parotid nodule biopsy specimen) and one was obtained
from urine from a symptomatic patient, with a total of 10 urine
samples being positive for NTM and no other causative agent
being identified, suggesting that they might be clinically rele-
vant, indicating probable disease.
Species identification. Fifty-two isolates from 38 patients
fulfilled the inclusion criteria and were subjected to rpoB gene
sequencing. Seven patients (patients 21, 22, 24, 25, 26, 27, and
28 in Table 1) had more than one isolate studied, and in all
cases, the rpoB sequences from the same patient showed 100%
similarity. BLAST analysis revealed that the rpoB sequences
from seven patients’ isolates (IAL 020, CRM 270, CRM 273,
CRM 622, CRM 552, IAL 034, and IAL36) were 100% similar
to the corresponding sequence of the epidemic strain, INCQS
594 (GenBank accession number EU117207). The rpoB se-
quences of 20 individual isolates and from the 3 isolates from
PA used for comparison showed the highest similarities to the
rpoB sequence of M. massiliense CIP 108297 (GenBank acces-
sion number AY593981.2). The sequences of 17 isolates
showed the highest similarity to the rpoB sequence of M.
bolletii CIP 108541 (accession number AY859692), and the
sequences of the isolates from one patient (patient 24) showed
the highest similarity to the rpoB sequence of M. abscessus
ATCC 19977 (GenBank accession number AY147164) The
close relationship found in comparing the rpoB nucleotide
sequences is shown in a phylogenetic tree (Fig. 1).
The results of PRA-hsp65 and rpoB gene sequencing of the
five independent isolates from patient 24 (Table 1) were in-
congruent. The isolates showed the M. abscessus type 2 PRA-
hsp65 pattern, which would be consistent with the identifica-
tion of M. abscessus subsp. bolletii, but the rpoB sequences
showed the highest similarity (99.71%) with the corresponding
sequence of the M. abscessus ATCC 19977 type strain. Addi-
tional sequence analysis of the hsp65, gyrA, and gyrB genes and
16S-23S ITS confirmed the identification of these isolates as M.
abscessus subsp. bolletii (data not shown).
Molecular typing. All patterns generated by PFGE with DraI
and AseI endonucleases were interpretable, resulting in 100%
typeability. Dendrograms obtained with DraI and AseI restriction
enzymes generated similar clustering patterns (Fig. 2).
The seven isolates whose rpoB sequences were 100% similar
to the corresponding sequence of the epidemic strain showed
PFGE patterns that grouped with two highly related DraI and
AseI PFGE patterns previously observed with the surgical out-
break isolates, which differ by only one fragment of approxi-
mately 50 kb (represented by isolates INCQS 594 and B52 in
Fig. 2, box A) (12, 28). The PFGE patterns of two isolates (IAL
036, CRM 552) were 100% similar to those of outbreak isolate
B52, the PFGE patterns of three isolates (IAL 020, IAL 034,
CRM 622) were 100% similar to those of isolate INCQS 594,
and two isolates (CRM 270, CRM 273) showed patterns highly
similar (91.45% similarity in DraI and AseI PFGE cluster
analyses) to the PFGE patterns of the epidemic strain (Fig. 2,
boxes A).
Patients from three different cities in SP (Presidente Pru-
dente, Sa˜o Paulo, and Jundiai) were infected by the same
strain. The isolates showed identical rpoB sequences and
PFGE patterns (Fig. 1 and Fig. 2, boxes B).
The PFGE patterns of the isolates collected from sputum or
FIG. 1. Neighbor-joining tree based on rpoB gene sequences. Re-
lationships between 46 taxa, including one isolate from each of the 38
patients from this study, three isolates from PA (INCQS 594, B52, and
B67), and the type strains of M. abscessus, M. chelonae, M. immuno-
genum, M. massiliense, and M. bolletii are shown. M. tuberculosis
H37Rv was included as an outgroup.
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blood from six patients (IAL 010, IAL 019, IAL 035, CRM 473,
CRM 375, and CRM 642) in states distant geographically (SP,
Mato Grosso [MT], and RJ) grouped with isolate B67, the only
postinjection abscess isolate from our previous study with iso-
lates from PA (28). Their PFGE patterns were closely related
(90.89% similarity with DraI and 94.78% with AseI) (Fig. 2,
boxes C). Moreover, the rpoB sequences of these isolates were
identical (Fig. 1).
Between two and five independent clinical isolates were
obtained from seven patients. In each case, rpoB sequences
and PFGE patterns were maintained in independent isolates
from each patient (Fig. 3). Exceptions were one additional
band in the AseI PFGE pattern of isolate IAL 025 compared
to the patterns of isolates IAL 024, IAL 026, and IAL 027 from
the same patient and a one-band polymorphism in the DraI
PFGE patterns in two isolates (CRM 409 and CRM 416) from
patient 26 (Fig. 3). These results were confirmed in two dif-
ferent experiments.
FIG. 2. Dendrograms of DraI and AseI PFGE patterns of single isolates from 38 patients, M. abscessusT ATCC 19977, M. chelonaeT ATCC
35752, M. immunogenumT ATCC 700505, M. massilienseT CCUG 48898, M. bolletiiT CCUG 50184, and three previously studied isolates, INCQS
594, B52, and B67 (19, 28). Dendrograms were prepared using the BioNumerics (version 5.1) program by the Dice unweighted-pair group method
with arithmetic means, based on 2% optimization and position tolerance. Isolates with highly similar (up to three band differences) PFGE patterns
are boxed. Boxes A, isolates showing high degrees of similarity to surgical epidemic isolates; boxes B, indistinguishable patterns for isolates from
three patients from different cities in SP; boxes C, isolates highly similar to a postinjection isolate from PA. Numbers at the upper left are percent
similarity.
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The remaining isolates showed diverse PFGE patterns,
pointing to the existence of a high degree of diversity in M.
abscessus subsp. bolletii isolates. This diversity was congruent
with the distinct rpoB sequences (sequevars).
The efficiency of the PFGE method for discrimination of M.
abscessus type 2 isolates was evaluated by comparison of the
patterns for 41 isolates, consisting of 1 isolate from each of the
38 patients, the postinjection abscess isolate from PA, M. mas-
siliense CCUG 48898, and M. bolletii CCUG 50184. No epide-
miological correlation was detected among the patients. Both
the typeability and reproducibility of PFGE were 100%. In the
evaluation of the discriminatory power of PFGE, 31 and 33
different PFGE banding profiles were discriminated by Dice
analysis after digestion with DraI and AseI, respectively, and
the calculated D values were 0.978 for DraI and 0.986 for AseI.
DISCUSSION
Fifty-two M. abscessus type 2 isolates from 38 patients pre-
sumably not related to the Brazilian surgical outbreak that
occurred between 2004 and 2008 were analyzed. Identification
results obtained with PRA-hsp65 and rpoB sequencing were
congruent for most (90.4%) isolates. Discordant results were
observed with five isolates from the same patient, and addi-
tional sequencing analysis allowed their classification as M.
abscessus subsp. bolletii, in agreement with the PRA-hsp65
pattern of M. abscessus type 2. A similar finding was already
reported in a previous study with a sputum isolate from PA
(19). Divergent identification obtained with rpoB and hsp65
analysis has been observed by other authors. Kim et al. (15)
identified two isolates as M. massiliense by rpoB sequence anal-
ysis and M. abscessus by hsp65 sequence analysis. These au-
thors used additional sodA and 16S-23S ITS sequencing anal-
ysis to confirm that both strains were M. massiliense. Zelazny et
al. (29) sequenced the hsp65, secA, and 16S-23S ITS regions
and identified 5 out of 42 clinical isolates as M. massiliense,
while rpoB identification resulted in identification as M. absces-
sus. Macheras et al. (21) obtained presumptive identifications
for 13 of 15 isolates with discordant identifications by analysis
of eight different housekeeping genes. These authors ques-
tioned the definition of species on the basis of a few gene
sequences and disputed the suitability of classifying M. absces-
sus, M. bolletii, and M. massiliense as three distinct species.
Recently, Leao et al. (18) demonstrated that M. bolletii and M.
massiliense cannot be separated from M. abscessus on the basis
of DNA-DNA hybridization and an extensive analysis of phe-
notypic and genotypic characteristics, which is consistent with
all these findings.
Another aspect that was examined in the present study was
the maintenance of the rpoB sequences and PFGE patterns in
isolates from the same patient collected at different times. The
stability of these markers during the period of this study was
confirmed, and only minor polymorphisms in PFGE patterns
were observed after analysis of independent isolates from the
same patient (Fig. 3). PFGE has been important in confirming
the clonality of the epidemic strain in earlier studies, but the
discriminatory power of PFGE for mycobacteria showing the
M. abscessus type 2 PRA-hsp65 pattern has not been evaluated
before (5, 12, 19, 28). This study allowed the calculation of the
FIG. 3. Reproducibility of PFGE patterns among multiple isolates from seven patients. Between two and five isolates from each patient were
analyzed by PFGE with DraI and AseI. The patterns obtained for isolates from the same patient were indistinguishable, except for the two
polymorphisms indicated by arrows.
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discriminatory power of PFGE using two different enzymes,
DraI and AseI. The calculated D value for DraI PFGE was
0.978, and for AseI PFGE it was 0.986. In a previous study, a
discriminatory index of 0.972 was obtained for PFGE using
DraI-digested DNA of isolates showing the M. abscessus type 1
PRA-hsp65 pattern (23). According to Hunter and Gaston
(14), an index higher than 0.90, associated with high typeability
and reproducibility, would be desirable for a typing method.
Using these criteria, we have confirmed that PFGE, using DraI
or AseI, is a suitable typing method for the discrimination of
isolates belonging to both proposed subspecies of M. abscessus.
PFGE helped to uncover the epidemic strain in isolates from
other clinical sources in three different states: Ceara (CE), RJ,
and SP. Three isolates (CRM 552, CRM 622, IAL 034), two
from RJ and one from SP, were obtained from bronchoalveo-
lar lavage fluid specimens. No specific investigation to isolate
mycobacteria from bronchoscopes was carried out, especially
because the procedure consisted of a routine evaluation for
diagnosis which did not include surveillance of medical de-
vices. No additional cases were reported in the same settings.
One isolate (IAL 020) was obtained from a single sputum
specimen in a city from SP in 2006, where just one case of
surgical-site infection related to the outbreak was reported 2
years later. One isolate was obtained from urine during diag-
nostic investigation of renal tuberculosis in a state in northeast
Brazil (CE) with only one reported case of surgical-site infec-
tion. The epidemic strain was also detected in a sputum spec-
imen from PA in previous studies from our group (7, 19).
The DraI and AseI PFGE patterns of two sputum isolates
(CRM 270 and CRM 273) were highly similar (91.45%) to
those of the epidemic strain, and the rpoB sequences were
100% similar. Both patients had confirmed pulmonary disease
and lived in RJ, where more than 1,000 possible surgical-site
infection cases were reported to ANVISA (12), but these iso-
lates harbor distinct biological properties, such as clarithromy-
cin resistance and susceptibility to glutaraldehyde at 1.5%,
while the epidemic strain is susceptible to clarithromycin and
tolerant of glutaraldehyde. Therefore, they may be considered
a different strain or a biological variant of the epidemic strain
(12, 20).
The finding of two additional clusters (Fig. 2, boxes B and C)
of isolates from different geographic regions and sources,
grouped by PFGE and rpoB sequencing, demonstrates that
some strains predominate and are widely distributed. This
could point to the existence of virulence factors or other prop-
erties that render these particular strains more pathogenic for
humans and more adapted to diverse environmental condi-
tions. These strains, as well as the epidemic strain, should be
monitored to map their spread and quickly detect new out-
breaks.
Mycobacteria can be quickly identified in the clinical labo-
ratory by the PRA-hsp65 method (6), which is also useful for
separation of the two proposed subspecies of M. abscessus, M.
abscessus subsp. abscessus, which shows the M. abscessus type 1
pattern, and M. abscessus subsp. bolletii, which shows the M.
abscessus type 2 pattern (17a).
In this study, M. abscessus type 2 isolates were considered
clinically significant in 30 out of 38 patients, 21 of whom had
confirmed NTM lung disease and 9 had probable disease.
Previous pulmonary tuberculosis treatment was a frequent
finding, but additional studies are necessary to confirm if tu-
berculosis can be considered a predisposing factor for pulmo-
nary disease caused by M. abscessus type 2 or if these patients
had undetected NTM lung disease from the beginning. The
identification of the epidemic strain that caused surgical infec-
tions in isolates obtained with the use of bronchoscopes points
to the possible dissemination of this particular strain by endos-
copy equipment, which has never been reported.
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